Skip to main content

10.06.2024 | Original Article

Incidence and predictors of diabetes mellitus: A 7- year community cohort follow-up of urban, adult Sri Lankans

verfasst von: S. T. De Silva, D. S. Ediriweera, M. A. Niriella, T. Beddage, A. Kasturiratne, A. Pathmeswaran, N. Kato, R. Wickramasinghe, H. J. de Silva

Erschienen in: International Journal of Diabetes in Developing Countries

Einloggen, um Zugang zu erhalten

Abstract

Background

There is limited data on the prevalence and outcome of prediabetes and the incidence of type 2 diabetes in South Asia.

Objective

We conducted a prospective, community-based study involving a cohort of urban adults in Sri Lanka, with a seven-year follow-up period.

Methods

Participants were selected using age-stratified random sampling, initially screened in 2007, and reevaluated in 2014. Structured interviews, anthropometric measurements, liver ultrasound, and biochemical and serological tests were performed on both occasions.

Results

A total of 2985 individuals were recruited in 2007 [54.8% women, median age (IQR) 53(47–59)]; 737 had diabetes [baseline prevalence 24.7% (95%CI:23.1–26.2)] and 525 had prediabetes [baseline prevalence 17.9% (95%CI:16.2–19.6)]. In 2014, 2148(71.6%) persons attended follow-up [57.5% women; median (IQR) 60(54–66) years], which included 1650 who did not have diabetes in 2007. By 2014, 436/1650(27.6%) persons had developed new diabetes [annual incidence 3.9% (95%CI:3.0–4.9)]. Poisson regression analysis showed that prediabetes, central obesity, low HDL, and nonalcoholic fatty liver disease at baseline were significantly associated with new-onset diabetes.
Of the 525 persons with prediabetes in 2007, 365(69.5%) were followed-up in 2014; 147/365(40.3%) remained in prediabetes, 201/365(55.1%) had progressed to diabetes, and 17/365(4.6%) had reverted to normoglycemia. The annual conversion rate of prediabetes to diabetes was 7.9%. An increase in waist circumference and low HDL levels from baseline predicted progression to diabetes.

Conclusions

The presence of prediabetes, central obesity, low HDL, and nonalcoholic fatty liver disease at baseline predicted new-onset diabetes, whereas increase in waist circumference and low HDL predicted conversion of prediabetes to diabetes. Targeted lifestyle interventions are essential for individuals with metabolic risks to prevent future diabetes.
Literatur
1.
Zurück zum Zitat WHO Global Health Estimates. Deaths by Cause, Age, Sex, by Country and by region, 2000–2016. Geneva: World Health Organization; 2016. WHO Global Health Estimates. Deaths by Cause, Age, Sex, by Country and by region, 2000–2016. Geneva: World Health Organization; 2016.
5.
Zurück zum Zitat Nanditha A, Ma RCW, Ramachandran A, Snehalatha C, Chan JCN, et al. Diabetes in Asia and the Pacific: Implications for the Global Epidemic. Diabetes Care. 2016;39(3):472–80.CrossRefPubMed Nanditha A, Ma RCW, Ramachandran A, Snehalatha C, Chan JCN, et al. Diabetes in Asia and the Pacific: Implications for the Global Epidemic. Diabetes Care. 2016;39(3):472–80.CrossRefPubMed
6.
Zurück zum Zitat Joshi SR, Parikh RM. India–diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India. 2007;55:323–4.PubMed Joshi SR, Parikh RM. India–diabetes capital of the world: now heading towards hypertension. J Assoc Physicians India. 2007;55:323–4.PubMed
7.
Zurück zum Zitat Tubak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high risk state for diabetes development. Lancet Diabetes. 2012;379(9833):2279–90.CrossRef Tubak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high risk state for diabetes development. Lancet Diabetes. 2012;379(9833):2279–90.CrossRef
8.
Zurück zum Zitat ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. https://doi.org/10.2337/dc23-S002. Erratum in: Diabetes Care. 2023 Feb 01;: Erratum in: Diabetes Care. 2023 Sep 1;46(9):1715. PMID: 36507649; PMCID: PMC9810477. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, Collins BS, Hilliard ME, Isaacs D, Johnson EL, Kahan S, Khunti K, Leon J, Lyons SK, Perry ML, Prahalad P, Pratley RE, Seley JJ, Stanton RC, Gabbay RA, on behalf of the American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. https://​doi.​org/​10.​2337/​dc23-S002. Erratum in: Diabetes Care. 2023 Feb 01;: Erratum in: Diabetes Care. 2023 Sep 1;46(9):1715. PMID: 36507649; PMCID: PMC9810477.
9.
Zurück zum Zitat Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care. 2010;33(2):442–9.CrossRefPubMedPubMedCentral Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care. 2010;33(2):442–9.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes. 2014;5(4):444–70.CrossRefPubMedPubMedCentral Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Del Cañizo-Gómez FJ. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes. 2014;5(4):444–70.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Bergman M, Buysschaert M, Schwarz PE, et al. Diabetes prevention: global health policy and perspectives from the ground. Diabetes Manag (Lond). 2012;2(4):309–21.CrossRefPubMed Bergman M, Buysschaert M, Schwarz PE, et al. Diabetes prevention: global health policy and perspectives from the ground. Diabetes Manag (Lond). 2012;2(4):309–21.CrossRefPubMed
14.
Zurück zum Zitat Dassanayake AS, Kasthuriratne A, Rindrajith S, et al. prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J Gastroenterol Hepatol. 2009;24:1284–8.CrossRefPubMed Dassanayake AS, Kasthuriratne A, Rindrajith S, et al. prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. J Gastroenterol Hepatol. 2009;24:1284–8.CrossRefPubMed
15.
Zurück zum Zitat De Silva ST, Niriella MA, Ediriweera DS, et al. Incidence and risk factors for metabolic syndrome among urban, adult Sri Lankans: a prospective, 7-year community cohort, follow-up study. Diabetol Metab Syndr. 2019;11:66.CrossRefPubMedPubMedCentral De Silva ST, Niriella MA, Ediriweera DS, et al. Incidence and risk factors for metabolic syndrome among urban, adult Sri Lankans: a prospective, 7-year community cohort, follow-up study. Diabetol Metab Syndr. 2019;11:66.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Chang CH, Shau WY, Jiang YD, et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: a national health insurance data set study. Diab Med. 2010;27(6):636–43.CrossRef Chang CH, Shau WY, Jiang YD, et al. Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: a national health insurance data set study. Diab Med. 2010;27(6):636–43.CrossRef
17.
Zurück zum Zitat Niriella MA, Pathmeswaran A, De Silva ST, et al. Incidence and risk factors for non-alcoholic fatty liver disease: A 7-year follow-up study among urban, adult Sri Lankans. Liver Int. 2017;37:1715–22.CrossRefPubMed Niriella MA, Pathmeswaran A, De Silva ST, et al. Incidence and risk factors for non-alcoholic fatty liver disease: A 7-year follow-up study among urban, adult Sri Lankans. Liver Int. 2017;37:1715–22.CrossRefPubMed
18.
Zurück zum Zitat Wang C, Li J, Xue H, et al. Type 2 diabetes mellitus incidence in Chinese: contributions of overweight and obesity. Diabetes Res Clin Pract. 2015;107(3):424–32.CrossRefPubMed Wang C, Li J, Xue H, et al. Type 2 diabetes mellitus incidence in Chinese: contributions of overweight and obesity. Diabetes Res Clin Pract. 2015;107(3):424–32.CrossRefPubMed
20.
Zurück zum Zitat Grønbaek H, Thomsen KL, Rungby J, et al. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes. Expert Rev Gastroenterol Hepatol. 2008;2:705–11.CrossRefPubMed Grønbaek H, Thomsen KL, Rungby J, et al. Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes. Expert Rev Gastroenterol Hepatol. 2008;2:705–11.CrossRefPubMed
21.
Zurück zum Zitat Kotronen A, Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:27–38.CrossRefPubMed Kotronen A, Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:27–38.CrossRefPubMed
22.
Zurück zum Zitat Kim CH, Park JY, Lee KU, et al. Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults. Diabet Med. 2008;25:476–781.CrossRefPubMed Kim CH, Park JY, Lee KU, et al. Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults. Diabet Med. 2008;25:476–781.CrossRefPubMed
23.
Zurück zum Zitat Kasturiratne A, Weerasinghe S, Dassanayake A, et al. Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. J of Gastroenterol and Hepatol. 2013;28:142–7.CrossRef Kasturiratne A, Weerasinghe S, Dassanayake A, et al. Influence of non-alcoholic fatty liver disease on the development of diabetes mellitus. J of Gastroenterol and Hepatol. 2013;28:142–7.CrossRef
24.
Zurück zum Zitat Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, Roverato A, Guaraldi G, Lonardo A. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31(5):936–44. https://doi.org/10.1111/jgh.13264. (PMID: 26667191).CrossRefPubMed Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, Roverato A, Guaraldi G, Lonardo A. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31(5):936–44. https://​doi.​org/​10.​1111/​jgh.​13264. (PMID: 26667191).CrossRefPubMed
25.
Zurück zum Zitat Fuster JJ, Ouchi N, Gokce N, et al. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circ Res. 2016;118(11):1786–807.CrossRefPubMedPubMedCentral Fuster JJ, Ouchi N, Gokce N, et al. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Circ Res. 2016;118(11):1786–807.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Lam BC, Koh GC, Chen C, et al. Comparison of Body Mass Index (BMI), Body Adiposity Index (BAI), Waist Circumference (WC), Waist-To-Hip Ratio (WHR) and Waist-To-Height Ratio (WHtR) as predictors of cardiovascular disease risk factors in an adult population in Singapore. PLoS ONE. 2015;10(4): e0122985.CrossRefPubMedPubMedCentral Lam BC, Koh GC, Chen C, et al. Comparison of Body Mass Index (BMI), Body Adiposity Index (BAI), Waist Circumference (WC), Waist-To-Hip Ratio (WHR) and Waist-To-Height Ratio (WHtR) as predictors of cardiovascular disease risk factors in an adult population in Singapore. PLoS ONE. 2015;10(4): e0122985.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Jung SH, Ha KH, Kim DJ. Visceral Fat Mass Has Stronger Associations with Diabetes and Prediabetes than Other Anthropometric Obesity Indicators among Korean Adults. Yonsei Med J. 2016;57(3):674–80.CrossRefPubMedPubMedCentral Jung SH, Ha KH, Kim DJ. Visceral Fat Mass Has Stronger Associations with Diabetes and Prediabetes than Other Anthropometric Obesity Indicators among Korean Adults. Yonsei Med J. 2016;57(3):674–80.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Garber A, Handelsman Y, Einhorn D, et al. Diagnosis and management of pre-diabetes in the continuum of hyperglycemia – When do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract. 2008;14:933–46.CrossRefPubMed Garber A, Handelsman Y, Einhorn D, et al. Diagnosis and management of pre-diabetes in the continuum of hyperglycemia – When do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract. 2008;14:933–46.CrossRefPubMed
29.
Zurück zum Zitat American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2015;38:S10. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2015;38:S10.
31.
Zurück zum Zitat Icks A, Haastert B, Gandjour A, et al. Cost-effectiveness analysis of different screening procedures for type 2 diabetes: The KORA Survey 2000. Diabetes Care. 2004;27:2120–8.CrossRefPubMed Icks A, Haastert B, Gandjour A, et al. Cost-effectiveness analysis of different screening procedures for type 2 diabetes: The KORA Survey 2000. Diabetes Care. 2004;27:2120–8.CrossRefPubMed
32.
Zurück zum Zitat Perreault L, Pan Q, Mather KJ, et al. Effect of regression from pre-diabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012;379(9833):2243–51.CrossRefPubMedPubMedCentral Perreault L, Pan Q, Mather KJ, et al. Effect of regression from pre-diabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012;379(9833):2243–51.CrossRefPubMedPubMedCentral
Metadaten
Titel
Incidence and predictors of diabetes mellitus: A 7- year community cohort follow-up of urban, adult Sri Lankans
verfasst von
S. T. De Silva
D. S. Ediriweera
M. A. Niriella
T. Beddage
A. Kasturiratne
A. Pathmeswaran
N. Kato
R. Wickramasinghe
H. J. de Silva
Publikationsdatum
10.06.2024
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-024-01365-x